FDA Approved: VPRIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved a supplemental application for VPRIV (velaglucerase alfa) from Takeda Pharmaceuticals America, Inc., resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease

Drugs mentioned

• VPRIV (VELAGLUCERASE ALFA)

Snippet

SUPPL AP for VPRIV (VELAGLUCERASE ALFA)